文献速递心血管MR

扩张型心肌病晚期钆增强的范围、位置和模式与结局的关系

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-09-12

本研究在874例扩张型心肌病患者中分析晚期钆增强(LGE)的范围、位置和模式与全因死亡及心源性猝死复合终点的关联。中位随访4.9年,34.3%患者存在非缺血性LGE;LGE范围与结局呈明显非线性关系,即使少量LGE也预测风险显著增加。室间隔LGE与死亡率增加相关,而心源性猝死风险在室间隔合并游离壁LGE时最高。

要点

  • 扩张型心肌病患者中,室间隔LGE即使范围很小也与死亡和心源性猝死风险大幅增加相关。
  • 心源性猝死风险在室间隔合并游离壁LGE时最高。
  • LGE范围超过少量后的增量价值及LGE模式的增量价值有限。

核心结论

  • 在扩张型心肌病中,室间隔LGE的存在与死亡和心源性猝死事件风险的大幅增加相关,即使范围很小;心源性猝死风险在室间隔合并游离壁LGE时最高;LGE范围超过少量后的增量价值及LGE模式的增量价值有限。

研究设计与样本

  • 研究为大型扩张型心肌病队列,共874例患者(588例男性,中位年龄52岁),中位随访4.9年;评估LGE范围、位置和模式与全因死亡及心源性猝死复合终点的关联。

关键影像表现/征象

  • 300例(34.3%)患者存在非缺血性LGE。
  • LGE范围与结局呈明显非线性关系,即使少量LGE也预测风险显著增加。
  • 室间隔LGE的存在与死亡率增加相关。
  • 心源性猝死与室间隔合并游离壁LGE的组合存在最相关。

诊断标准与关键数值

  • LGE范围0至2.55%组全因死亡校正风险比1.59(95%CI 0.99至2.55),心源性猝死终点校正风险比2.79(95%CI 1.42至5.49)。
  • LGE范围2.55%至5.10%组全因死亡校正风险比1.56(95%CI 0.96至2.54),心源性猝死终点校正风险比3.86(95%CI 2.09至7.13)。
  • LGE范围大于5.10%组全因死亡校正风险比2.31(95%CI 1.50至3.55),心源性猝死终点校正风险比4.87(95%CI 2.78至8.53)。
  • 使用LGE存在和位置的预测模型优于基于LGE范围或模式的模型。

临床应用与阅片要点

  • 在扩张型心肌病患者的阅片和报告中,应关注LGE的存在及位置,尤其是室间隔和游离壁受累。
  • 即使LGE范围很小,也应提示其与死亡和心源性猝死风险增加相关。
  • 室间隔合并游离壁LGE提示心源性猝死风险最高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to investigate the association between the extent, location, and pattern of late gadolinium enhancement (LGE) and outcome in a large dilated cardiomyopathy (DCM) cohort.

BACKGROUND: The relationship between LGE and prognosis in DCM is incompletely understood.

METHODS: The authors examined the association between LGE and all-cause mortality and a sudden cardiac death (SCD) composite based on the extent, location, and pattern of LGE in DCM.

RESULTS: Of 874 patients (588 men, median age 52 years) followed for a median of 4.9 years, 300 (34.3%) had nonischemic LGE. Estimated adjusted hazard ratios for patients with an LGE extent of 0 to 2.55%, 2.55% to 5.10%, and >5.10%, respectively, were 1.59 (95% confidence interval [CI]: 0.99 to 2.55), 1.56 (95% CI: 0.96 to 2.54), and 2.31 (95% CI: 1.50 to 3.55) for all-cause mortality, and 2.79 (95% CI: 1.42 to 5.49), 3.86 (95% CI: 2.09 to 7.13), and 4.87 (95% CI: 2.78 to 8.53) for the SCD endpoint. There was a marked nonlinear relationship between LGE extent and outcome such that even small amounts of LGE predicted a substantial increase in risk. The presence of septal LGE was associated with increased mortality, but SCD was most associated with the combined presence of septal and free-wall LGE. Predictive models using LGE presence and location were superior to models based on LGE extent or pattern.

CONCLUSIONS: In DCM, the presence of septal LGE is associated with a large increase in the risk of death and SCD events, even when the extent is small. SCD risk is greatest with concomitant septal and free-wall LGE. The incremental value of LGE extent beyond small amounts and LGE pattern is limited.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Halliday BP, Baksi AJ, Gulati A, et al. Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement. JACC Cardiovasc Imaging. 2018. PMID: 30219397. doi:10.1016/j.jcmg.2018.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。